Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: J Allergy Clin Immunol. 2021 Aug 21;149(3):1044–1059.e5. doi: 10.1016/j.jaci.2021.07.041

Figure 8.

Figure 8.

IFN-β inhibits GATA3 expression in lung ILC2s in vivo. (A) Experimental model. Naïve BALB/c were administered i.n. IFN-β or PBS for 3 consecutive days. GATA3 protein expression in lung ILC2s was analyzed by gating on the Lin−CD25+CD44high population. (B) Representative scattergrams and histograms are shown. (C) MFI for GATA3 protein and proportion of GATA3-negative cells within the lung ILC2 population. (D) Proportion of lung ILC2s within the Lin− cell population is shown (n.s., not significant). Data are presented as the mean ± SEM (n = 3-4 in each group) and are representative of two experiments. **p<0.01 between the groups indicated by horizontal lines.